An Interview with Pavneet Gulati of Ceuticoz

An unique interview with Pavneet Gulati – Head of Advertising at Ceuticoz

On this insightful interview, Pavneet Gulati, Head of Advertising at Ceuticoz, shares his experience on navigating the dynamic pharmaceutical panorama.

With a concentrate on revolutionary advertising methods and buyer engagement, he reveals how Ceuticoz is redefining its model presence and connecting with healthcare professionals and shoppers alike.

How has the medical aesthetics and cosmeceuticals business developed in recent times?

Pavneet Gulati: The medical aesthetics and cosmeceuticals business has skilled vital transformation in recent times, pushed by technological developments, shifting shopper preferences, and scientific innovation.

Science-Backed Skincare is now the brand new normal. Shoppers are not glad with simply “pure” or “luxurious” claims – they demand clinically confirmed, ingredient-focused, and dermatologist-recommended options.

Lively components akin to retinoids, niacinamide, peptides, ceramides, and development components, all supported by information and analysis, have seen an increase in recognition. This has resulted in an elevated belief in medical-grade and cosmeceutical manufacturers that function on the intersection of dermatology and skincare.

Medical aesthetics clinics are more and more combining skilled therapies (like lasers, microneedling, and chemical peels) with cosmeceutical help to boost outcomes. Many cosmeceutical manufacturers at the moment are creating post-procedure skincare traces geared toward therapeutic, soothing, and sustaining medical outcomes.

We’re additionally witnessing the globalization of ingredient traits, with the rise of Okay-beauty, J-beauty, and Ayurvedic derivatives influencing international formulations. Indian-origin skincare manufacturers, akin to Ceuticoz, are rising as globally aggressive, providing science-driven merchandise that ship confirmed outcomes and world-class high quality.

The demand for personalised skincare is booming, fueled by AI pores and skin evaluation apps, tele-dermatology, and digital diagnostic instruments. Shoppers at the moment are searching for customized routines tailor-made to their pores and skin sort, geography, life-style, and particular issues, transferring away from the one-size-fits-all method.

Lastly, social media has sparked the rise of a brand new technology of skintellectual shoppers who actively analysis components and demand transparency. Dermatologists and skincare professionals themselves have turn out to be influencers, constructing belief in science-led manufacturers.

What are Ceuticoz’s growth plans in India and worldwide markets?

Pavneet Gulati: Ceuticoz is dedicated to strengthening its moral market presence in India by changing into the popular model for medical dermatology prescriptions.

We’re enhancing medical engagement, increasing into Tier 2 and three cities, and launching education-driven initiatives to construct belief. Following the success of our Ivorine Brightening Vary, we’re diversifying into post-procedure skincare options.

Internationally, Ceuticoz is current in 10+ nations, with a robust foothold in Canada and ongoing growth within the Center East and Southeast Asia. Our imaginative and prescient is to determine Ceuticoz as a number one international Indian cosmeceutical model—trusted by dermatologists, liked by sufferers, and backed by science.

Which new markets or areas are you focusing on within the coming 12 months?

Pavneet Gulati: Within the coming 12 months, Ceuticoz is focusing on the USA, UAE, and Saudi Arabia as key markets for growth. These areas provide vital development potential, with a rising demand for science-backed, dermatologist-recommended skincare merchandise.

We’re actively engaged on establishing strategic partnerships with native distributors, skincare clinics, and dermatologists to strengthen our presence and construct belief inside these markets.

Our objective is to place Ceuticoz as a number one alternative within the international cosmeceutical area, providing high-quality, clinically confirmed skincare options to fulfill the varied wants of shoppers in these areas.

How is Ceuticoz differentiating itself from different cosmeceutical manufacturers?

Ceuticoz is strategically differentiating itself from different cosmeceutical manufacturers by combining medical credibility, affordability, and Indian dermatological relevance—whereas gearing up for international competitiveness.

Each Ceuticoz product is clinically pushed and dermatologically validated, designed to deal with particular pores and skin issues like zits, pigmentation, sensitivity, and growing old.

We use evidence-based actives like Tranexamic Acid, Niacinamide, Peptides, Retinoids, and patented components with confirmed outcomes.There’s a main emphasis on derma-grade efficacy, not simply beauty enchantment, i.e. bridging the hole between prescription drugs and skincare.

Ceuticoz operates on the intersection of medical dermatology and fashionable skincare, creating options that docs belief and sufferers love. We boast of sturdy in-clinic presence and medical engagement with dermatologists throughout India.

Key Differentiator – Endorsed by dermatologists as each a remedy help and beauty enhancement, we provide medical-grade skincare at accessible costs, making science-backed pores and skin well being options accessible to a wider inhabitants.

That is extremely related in India and different creating markets, the place value typically limits entry to clinical-grade skincare.

Ceuticoz stands aside by providing dermatologist-backed, medical-grade skincare that’s inexpensive, moral, and globally related—whereas being deeply rooted in Indian dermatology and scientific integrity

What’s Ceuticoz’s present whole income, and what’s the projected income for FY 2025-26?

Pavneet Gulati: Ceuticoz’s projected India income for FY 2025-26 is 50 Crores. This development is pushed by our efforts to increase our product portfolio, strengthen market presence, and enter new areas, each domestically and internationally.

Our concentrate on innovation, dermatologist collaborations, and neighborhood engagement will assist obtain this goal and guarantee long-term development.

How has the corporate carried out by way of year-on-year development?

Pavneet Gulati: Final 3 12 months CAGR – 33%

What are the important thing monetary highlights from the previous 12 months?

• Achieved highest-ever month-to-month gross sales in November after which in December in 2024 crossing 4 Cr
• Sturdy double-digit development in income in comparison with the earlier 12 months
• Ceuticoz entered the Canadian market with 8+ SKUs, driving new worldwide income streams.
• Operations began in Kenya and South Africa with greater than 20 SKUs
• Strengthened moral dermatology market presence in Odisha and Bengaluru, reinforcing a dedication to dermatological excellence.
• Launched 7 new pores and skin brightening merchandise beneath the sub-brand of IVORINE

Are there any plans for brand spanking new product launches or R&D initiatives?

Pavneet Gulati: Sure, we’re working to launch the pediatrics vary with 7 merchandise in September 2025. The formulation and packaging has been finalised for all of the merchandise and presently now we have put them for medical and shopper research.

How does Ceuticoz plan to strengthen its international footprint?

Pavneet Gulati: By focusing on areas with vital Indian and South Asian diaspora akin to Canada (already launched), USA, UK, UAE and  Singapore.

These markets have a robust want for tailor-made skincare that addresses pigmentation, zits, sensitivity, and growing old in melanin-rich pores and skin—which Ceuticoz is uniquely positioned to serve.

One of many core areas of focus might be to construct belief by means of medical endorsement, not simply retail advertising. Partnering with worldwide dermatologists and clinics to construct credibility, Launching with a doctor-first mannequin in key international cities, mirroring its Indian method.

We can even be taking part in worldwide conferences and exhibitions (e.g., already showcased on the Worldwide Dermatological Convention, New Delhi and 5 worldwide derma exhibitions within the final 2 years) to construct authority and belief.

You will need to point out that we have to be globally compliant to unlock development in regulated markets.We’re already Investing in worldwide regulatory approvals (like Well being Canada, FDA-compliant labeling, EU pointers) and Tailoring packaging and claims to native compliance and shopper preferences.

What are the corporate’s enterprise targets for the subsequent 5 years?

Pavneet Gulati: Ceuticoz’s India’s enterprise targets for the subsequent 5 years concentrate on attaining sustainable development and increasing our international presence.

We purpose for a CAGR of 30–35%, with a goal income of ₹150–200 Cr by FY 2029-30, up from the present ₹25–30 Cr annual run price. Our technique might be pushed by moral markets, product diversification, and international growth.

By FY 2030, we plan to derive 35–40% of our income from worldwide markets, with a presence in additional than 25 nations. Moreover, we purpose to construct a community of 30,000+ prescribing dermatologists and cosmetologists to strengthen our market place and guarantee continued success.

Pavneet Gulati’s imaginative and prescient for Ceuticoz highlights the significance of creativity and adaptableness in advertising.

By leveraging digital instruments and storytelling, he’s paving the best way for impactful campaigns that resonate with audiences, in the end enhancing the model’s popularity and fostering belief within the pharmaceutical business.

Discover Success story of Indian entrepreneurs & startups at SugerMint. Observe us on Twitter, Instagram, Fb, LinkedIn